Paul F. Truex
2014
In 2014, Paul F. Truex earned a total compensation of $1.4M as Former CEO and Director at Anthera Pharmaceuticals, a 56% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $401,718 |
---|---|
Option Awards | $449,759 |
Salary | $515,000 |
Stock Awards | $12,750 |
Total | $1,379,227 |
Truex received $515K in salary, accounting for 37% of the total pay in 2014.
Truex also received $401.7K in non-equity incentive plan, $449.8K in option awards and $12.8K in stock awards.
Rankings
In 2014, Paul F. Truex's compensation ranked 6,158th out of 13,032 executives tracked by ExecPay. In other words, Truex earned more than 52.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,158 | 53rd |
Manufacturing | 2,238 | 55th |
Chemicals And Allied Products | 746 | 56th |
Drugs | 583 | 57th |
Pharmaceutical Preparations | 446 | 57th |
Truex's colleagues
We found six more compensation records of executives who worked with Paul F. Truex at Anthera Pharmaceuticals in 2014.
2014
Colin Hislop
Anthera Pharmaceuticals
Chief Medical Officer
2014
Debra Odink
Anthera Pharmaceuticals
Chief Technology Officer
2014
May Liu
Anthera Pharmaceuticals
SVP, Finance & Administration
2014
Chuck Olson
Anthera Pharmaceuticals
Chief Technology Officer
2014
Klara Dickinson
Anthera Pharmaceuticals
Senior Vice President Chief Regulatory Officer
2014
Klara Dickinson-Eason
Anthera Pharmaceuticals